Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13425
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCohen, Nen
dc.contributor.authorGilbert, Richard Een
dc.contributor.authorWirth, Aen
dc.contributor.authorCasley, David Jen
dc.contributor.authorJerums, Georgeen
dc.date.accessioned2015-05-16T03:16:24Z
dc.date.available2015-05-16T03:16:24Z
dc.date.issued1996-04-01en
dc.identifier.citationThe Journal of Clinical Endocrinology and Metabolism; 81(4): 1411-5en
dc.identifier.govdoc8636343en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13425en
dc.description.abstractAssessment of mineralocorticoid replacement therapy in Addison's disease relies on clinical features and laboratory measurements, including plasma renin and potassium. Previous studies have questioned the value of measuring the plasma renin concentration (PRC), particularly in the setting of fludrocortisone overreplacement. The aim of this study was to evaluate the usefulness of plasma atrial natriuretic peptide (ANP) measurements as a marker of sodium and volume status in Addison's disease. Fourteen patients with Addison's disease receiving their usual glucocorticoid doses were placed on various doses of fludrocortisone (FC; 0 mg, 0.05 mg, 0.1 mg and 0.2 mg) in random order for four 2-week periods. At the end of each period, blood pressure and clinical symptoms were assessed, and blood was drawn for measurement of PRC and ANP levels. PRC was significantly elevated in patients receiving placebo (54.2 +/- 57.9 ng/mL x h) compared with PRC in those receiving baseline FC (24.7 +/- 42.4 ng/mL x h), 0.1 mg FC (15.2 +/- 25.9 ng/mL x h), and 0.2 mg FC (5.5 +/- 5.7 ng/mL x h). ANP levels were measured by either an extraction method (ANP(ext)) or directly from plasma (ANP(dir)). ANP(dir) was significantly elevated at 0.2 mg FC (87.1 +/- 20.1 pg/mL) compared with baseline (63.3 +/- 8.1 pg/mL), placebo (56.1 +/- 5.5 pg/mL), 0.05 mg FC (60.5 +/- 16.0 pg/mL), and 0.1 mg FC (65.4 +/- 13.7 pg/mL) values. ANP(ext) was elevated in patients receiving 0.2 mg FC (42.7 +/- 41.8 pg/mL) compared with that in patients receiving placebo (7.9 +/- 5.4 pg/mL), 0.05 mg FC (16.2 +/- 11.2 pg/mL), or 0.1 mg FC (19.7 +/- 11.1 pg/mL). Our data suggest that PRC is of value in determining mineralocorticoid underreplacement, whereas ANP is a more sensitive index of FC overreplacement. ANP levels may, therefore, be complementary to PRC in adjustment of mineralocorticoid doses in the upper dose range, where clinical symptoms and signs appear to be of little value.en
dc.language.isoenen
dc.subject.otherAddison Disease.blood.drug therapy.physiopathologyen
dc.subject.otherAdulten
dc.subject.otherAgeden
dc.subject.otherAtrial Natriuretic Factor.blooden
dc.subject.otherBlood Pressureen
dc.subject.otherCortisone.analogs & derivatives.therapeutic useen
dc.subject.otherDose-Response Relationship, Drugen
dc.subject.otherDrug Monitoring.methodsen
dc.subject.otherFemaleen
dc.subject.otherFludrocortisone.adverse effects.therapeutic useen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherMineralocorticoids.adverse effects.therapeutic useen
dc.subject.otherPotassium.blood.urineen
dc.subject.otherPrednisolone.therapeutic useen
dc.subject.otherRenin.blooden
dc.titleAtrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of Clinical Endocrinology and Metabolismen
dc.identifier.affiliationDepartment of Endocrinology, Austin Hospital, Victoria, Australiaen
dc.identifier.doi10.1210/jcem.81.4.8636343en
dc.description.pages1411-5en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/8636343en
dc.type.austinJournal Articleen
local.name.researcherJerums, George
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

30
checked on Jan 8, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.